135 related articles for article (PubMed ID: 12207498)
1. Metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) by human cytochrome P450-dependent monooxygenase systems.
Inouye K; Shinkyo R; Takita T; Ohta M; Sakaki T
J Agric Food Chem; 2002 Sep; 50(19):5496-502. PubMed ID: 12207498
[TBL] [Abstract][Full Text] [Related]
2. Biodegradation of polychlorinated dibenzo-p-dioxins by recombinant yeast expressing rat CYP1A subfamily.
Sakaki T; Shinkyo R; Takita T; Ohta M; Inouye K
Arch Biochem Biophys; 2002 May; 401(1):91-8. PubMed ID: 12054491
[TBL] [Abstract][Full Text] [Related]
3. Metabolic pathways of dioxin by CYP1A1: species difference between rat and human CYP1A subfamily in the metabolism of dioxins.
Shinkyo R; Sakaki T; Ohta M; Inouye K
Arch Biochem Biophys; 2003 Jan; 409(1):180-7. PubMed ID: 12464257
[TBL] [Abstract][Full Text] [Related]
4. Generation of 2,3,7,8-TCDD-metabolizing enzyme by modifying rat CYP1A1 through site-directed mutagenesis.
Shinkyo R; Sakaki T; Takita T; Ohta M; Inouye K
Biochem Biophys Res Commun; 2003 Aug; 308(3):511-7. PubMed ID: 12914780
[TBL] [Abstract][Full Text] [Related]
5. Sequential metabolism of 2,3,7-trichlorodibenzo-p-dioxin (2,3,7-triCDD) by cytochrome P450 and UDP-glucuronosyltransferase in human liver microsomes.
Kasai N; Sakaki T; Shinkyo R; Ikushiro S; Iyanagi T; Kamao M; Okano T; Ohta M; Inouye K
Drug Metab Dispos; 2004 Aug; 32(8):870-5. PubMed ID: 15258113
[TBL] [Abstract][Full Text] [Related]
6. Mammalian cytochrome P450-dependent metabolism of polychlorinated dibenzo-p-dioxins and coplanar polychlorinated biphenyls.
Inui H; Itoh T; Yamamoto K; Ikushiro S; Sakaki T
Int J Mol Sci; 2014 Aug; 15(8):14044-57. PubMed ID: 25123135
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of polychlorinated dibenzo-p-dioxins by rat liver microsomes.
Hu K; Bunce NJ
J Biochem Mol Toxicol; 1999; 13(6):307-15. PubMed ID: 10487418
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics of dioxins and other organochlorine compounds in Japanese people: association with hepatic CYP1A2 expression levels.
Watanabe MX; Kunisue T; Ueda N; Nose M; Tanabe S; Iwata H
Environ Int; 2013 Mar; 53():53-61. PubMed ID: 23333656
[TBL] [Abstract][Full Text] [Related]
9. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
11. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
12. Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).
Schulz TG; Neubert D; Davies DS; Edwards RJ
Biochim Biophys Acta; 1996 Nov; 1298(1):131-40. PubMed ID: 8948497
[TBL] [Abstract][Full Text] [Related]
13. Biodegradation of dioxins by recombinant Escherichia coli expressing rat CYP1A1 or its mutant.
Shinkyo R; Kamakura M; Ikushiro S; Inouye K; Sakaki T
Appl Microbiol Biotechnol; 2006 Sep; 72(3):584-90. PubMed ID: 16489453
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT
Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
17. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
[TBL] [Abstract][Full Text] [Related]
18. Structural-functional adaptations of porcine CYP1A1 to metabolize polychlorinated dibenzo-p-dioxins.
Molcan T; Swigonska S; Orlowska K; Myszczynski K; Nynca A; Sadowska A; Ruszkowska M; Jastrzebski JP; Ciereszko RE
Chemosphere; 2017 Feb; 168():205-216. PubMed ID: 27783961
[TBL] [Abstract][Full Text] [Related]
19. Possibility of application of cytochrome P450 to bioremediation of dioxins.
Sakaki T; Yamamoto K; Ikushiro S
Biotechnol Appl Biochem; 2013; 60(1):65-70. PubMed ID: 23586993
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
